Clarke John K
Director at ATYR; Director at ALNY; Director at MOMENTA PHARMACEUTICALS INC, and 1 more
- Sold, on record
- $8.4M
- Dollars the filings state
- Form 4 sales
- 8
- Latest May 21, 2021
- Form 144 notices
- 0
- Proposed sales
- Quarters with a sale
- 0 of the last 8
- No sale in two years
- Companies
- 4
- Filed as an executive or holder
Companies
- ATYRaTYR PHARMA INCDirector
- ALNYALNYLAM PHARMACEUTICALS, INC.Director
- MOMENTA PHARMACEUTICALS INCDirector
- VISICU INCDirector, 10% owner
Sales by reason
0
Routine
5
Plan not stated
0
No plan
3
Unusual
Form 4 sales per year, every sale on record.
Sales by company
- VISICU INC418,500 shares
- ALNY50,000 shares
- MOMENTA PHARMACEUTICALS INC38,400 shares
- ATYR17,500 shares
Shares sold, every Form 4 sale on record.
Timeline
- May 21, 2021Plan not stated
Sold 2.3% of their holdings
$11k2,500 shares at $4.34
- Sep 2, 2020Plan not stated
Sold 6.2% of their holdings
$30k7,360 shares at $4.01
- Aug 27, 2020Plan not stated
Sold 6.1% of their holdings
$32k7,640 shares at $4.15
- May 31, 2018Unusual
Sold 62.8% of their holdings
$1.5M15,000 shares at $100.31
- May 12, 2015Unusual
Sold 35.7% of their holdings
$766k38,400 shares at $19.96
- May 21, 2014Unusual
Sold 100% of their holdings
$1.9M35,000 shares at $53.80
- Nov 30, 2006Plan not stated
Sold 10.4% of their holdings
$3.9M387,000 shares at $10.04
- Nov 16, 2006Plan not stated
Sold 0.8% of their holdings
$316k31,500 shares at $10.04
8 of 8
Every transaction
| Traded | Filed | Stock | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|
| May 22, 2024 | May 23, 2024 | ATYR | Director | AwardedStock Option (right to buy) | 24,000 | 24,000 | SEC | ||
| May 17, 2023 | May 19, 2023 | ATYR | Director | AwardedStock Option (right to buy) | 12,000 | 12,000 | SEC | ||
| Apr 26, 2023 | Apr 28, 2023 | ATYR | Director | Exercised or settledRestricted Stock Unit | 6,000 | 0 | SEC | ||
| Apr 26, 2023 | Apr 28, 2023 | ATYR | Director | Exercised options | 6,000 | 19,797 | SEC | ||
| Apr 26, 2022 | Apr 28, 2022 | ATYR | Director | AwardedRestricted Stock Units | 6,000 | 6,000 | SEC | ||
| May 21, 2021 | May 25, 2021 | ATYR | Director | Sold | 2,500 | $4.34 | $11k | 108,083 | SEC |
| Apr 28, 2021 | Apr 29, 2021 | ATYR | Director | AwardedStock Option (right to buy) | 1,428 | 1,428 | SEC | ||
| Sep 2, 2020 | Sep 3, 2020 | ATYR | Director | Sold | 7,360 | $4.01 | $30k | 110,583 | SEC |
| Aug 27, 2020 | Aug 28, 2020 | ATYR | Director | Sold | 7,640 | $4.15 | $32k | 117,943 | SEC |
| May 6, 2020 | May 8, 2020 | ATYR | Director | AwardedStock Option (right to buy) | 1,428 | 1,428 | SEC | ||
| May 8, 2019 | May 10, 2019 | ATYR | Director | AwardedStock Option (right to buy) | 20,000 | 20,000 | SEC | ||
| Jun 20, 2018 | Jun 22, 2018 | ALNY | Director | AwardedStock Option (right to buy) | 9,000 | 9,000 | SEC | ||
| May 31, 2018 | Jun 4, 2018 | ALNY | Director | Sold | 15,000 | $100.31 | $1.5M | 8,891 | SEC |
| May 31, 2018 | Jun 4, 2018 | ALNY | Director | Exercised or settledStock Option (right to buy) | 15,000 | 0 | SEC | ||
| May 31, 2018 | Jun 4, 2018 | ALNY | Director | Exercised options | 15,000 | $27.28 | $409k | 23,891 | SEC |
| May 15, 2018 | May 17, 2018 | ATYR | Director | AwardedStock Option (right to buy) | 20,000 | 20,000 | SEC | ||
| Jun 2, 2017 | Jun 6, 2017 | ALNY | Director | AwardedStock Option (right to buy) | 11,250 | 11,250 | SEC | ||
| May 9, 2017 | May 11, 2017 | ATYR | Director | AwardedStock Option (right to buy) | 20,000 | 20,000 | SEC | ||
| Jun 3, 2016 | Jun 7, 2016 | ALNY | Director | AwardedStock Option (right to buy) | 11,250 | 11,250 | SEC | ||
| May 24, 2016 | May 26, 2016 | ATYR | Director | AwardedStock Option (right to buy) | 18,000 | 18,000 | SEC | ||
| Jan 27, 2016 | Jan 29, 2016 | ATYR | Director | AwardedStock Option (right to buy) | 19,428 | 19,428 | SEC | ||
| Jul 8, 2015 | Jul 10, 2015 | ATYR | Director | AwardedStock Option (right to buy) | 6,286 | 6,286 | SEC | ||
| Jun 10, 2015 | Jun 11, 2015 | MOMENTA PHARMACEUTICALS INC | Director | AwardedStock Option (Right to Buy) | 17,750 | 176,350 | SEC | ||
| Jun 1, 2015 | Jun 3, 2015 | ALNY | Director | AwardedStock Option (right to buy) | 11,250 | 11,250 | SEC | ||
| May 12, 2015 | May 14, 2015 | ATYR | Director | ConvertedSeries E Redeemable Convertible Preferred Stock | 14.9M | 0 | SEC | ||
| May 12, 2015 | May 14, 2015 | ATYR | Director | Converted | 1.9M | 1.8M | SEC | ||
| May 12, 2015 | May 14, 2015 | MOMENTA PHARMACEUTICALS INC | Director | Sold | 38,400 | $19.96 | $766k | 69,123 | SEC |
| May 12, 2015 | May 14, 2015 | MOMENTA PHARMACEUTICALS INC | Director | Exercised or settledStock Option (Right to Buy) | 38,400 | 0 | SEC | ||
| May 12, 2015 | May 14, 2015 | MOMENTA PHARMACEUTICALS INC | Director | Exercised options | 38,400 | $10.44 | $401k | 107,523 | SEC |
| Jun 12, 2014 | Jun 13, 2014 | MOMENTA PHARMACEUTICALS INC | Director | AwardedStock Option (Right to Buy) | 17,750 | 197,000 | SEC | ||
| Jun 5, 2014 | Jun 6, 2014 | ALNY | Director | AwardedStock Option (right to buy) | 15,000 | 15,000 | SEC | ||
| May 21, 2014 | May 23, 2014 | ALNY | Director | Sold | 35,000 | $53.80 | $1.9M | 0 | SEC |
| May 21, 2014 | May 23, 2014 | ALNY | Director | Exercised or settledStock Option (Right to Buy) | 35,000 | 0 | SEC | ||
| May 21, 2014 | May 23, 2014 | ALNY | Director | Exercised options | 35,000 | $13.05 | $457k | 35,000 | SEC |
| Jun 12, 2013 | Jun 13, 2013 | VSTM | Director | Bought | 23,171 | $9.60 | $222k | 2.3M | SEC |
| Jun 11, 2013 | Jun 13, 2013 | MOMENTA PHARMACEUTICALS INC | Director | AwardedStock Option (Right to Buy) | 17,750 | 179,250 | SEC | ||
| Jun 11, 2013 | Jun 12, 2013 | VSTM | Director | Bought | 25,000 | $9.22 | $231k | 2.3M | SEC |
| Jun 6, 2013 | Jun 10, 2013 | ALNY | Director | AwardedStock Option (Right to Buy) | 15,000 | 15,000 | SEC | ||
| Jun 4, 2013 | Jun 6, 2013 | VSTM | Director | AwardedStock Option (Right to Buy) | 12,500 | 12,500 | SEC | ||
| May 13, 2013 | May 15, 2013 | VSTM | Director | Bought | 25,000 | $9.74 | $244k | 2.3M | SEC |
| May 1, 2013 | May 3, 2013 | VSTM | Director | Bought | 10,000 | $9.66 | $97k | 2.3M | SEC |
| Apr 17, 2013 | Apr 19, 2013 | VSTM | Director | Bought | 5,631 | $9.50 | $53k | 2.2M | SEC |
| Dec 18, 2012 | Dec 20, 2012 | VSTM | Director | Bought | 6,193 | $7.87 | $49k | 2.2M | SEC |
| Jun 21, 2012 | Jun 25, 2012 | ALNY | Director | AwardedStock Option (Right to Buy) | 15,000 | 15,000 | SEC | ||
| Jun 13, 2012 | Jun 15, 2012 | MOMENTA PHARMACEUTICALS INC | Director | AwardedStock Option (Right to Buy) | 17,750 | 161,500 | SEC | ||
| Mar 6, 2012 | Mar 8, 2012 | VSTM | Director | AwardedStock Option (Right to Buy) | 12,500 | 12,500 | SEC | ||
| Feb 1, 2012 | Feb 3, 2012 | VSTM | Director | Bought | 250,000 | $10.00 | $2.5M | 2.2M | SEC |
| Feb 1, 2012 | Feb 3, 2012 | VSTM | Director | ConvertedSeries A Preferred Stock | 6.9M | 0 | SEC | ||
| Feb 1, 2012 | Feb 3, 2012 | VSTM | Director | Converted | 2M | 2M | SEC | ||
| Jun 14, 2011 | Jun 15, 2011 | MOMENTA PHARMACEUTICALS INC | Director | AwardedStock Option (Right to Buy) | 17,750 | 143,750 | SEC |
Page 1
Sales and notices (8)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| May 21, 2021 | May 25, 2021 | ATYR | Director | Form 4 sale | 2,500 | $11k | 2.3% | Plan not stated | SEC |
| Sep 2, 2020 | Sep 3, 2020 | ATYR | Director | Form 4 sale | 7,360 | $30k | 6.2% | Plan not stated | SEC |
| Aug 27, 2020 | Aug 28, 2020 | ATYR | Director | Form 4 sale | 7,640 | $32k | 6.1% | Plan not stated | SEC |
| May 31, 2018 | Jun 4, 2018 | ALNY | Director | Form 4 sale | 15,000 | $1.5M | 62.8% | Unusual | SEC |
| May 12, 2015 | May 14, 2015 | MOMENTA PHARMACEUTICALS INC | Director | Form 4 sale | 38,400 | $766k | 35.7% | Unusual | SEC |
| May 21, 2014 | May 23, 2014 | ALNY | Director | Form 4 sale | 35,000 | $1.9M | 100.0% | Unusual | SEC |
| Nov 30, 2006 | Dec 4, 2006 | VISICU INC | Director, 10% owner | Form 4 sale | 387,000 | $3.9M | 10.4% | Plan not stated | SEC |
| Nov 16, 2006 | Nov 20, 2006 | VISICU INC | Director, 10% owner | Form 4 sale | 31,500 | $316k | 0.8% | Plan not stated | SEC |